AN UNBIASED VIEW OF SITUS JUDI MBL77

gene in individuals relapsing after treatment While using the BCL2 antagonist venetoclax. 66 Resistance to those agents continues to be related to these mutations in all around 70% of instances, Though they are generally subclonal and their specific part leading to resistance needs to be established.In the last decades, the amount of people referre